Meeker David P
SEC CIK 1385155 · EDGAR
BoughtSold
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-14 19:37 | 2026-09-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | $6.05 | +50.0K | 289.3K | +21% | +$302.5K |
| DMT | 2026-09-14 19:37 | 2026-09-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $102.67 | -50.0K | 239.3K | -17% | -$5.13M |
| 2026-06-22 19:28 | 2026-06-17 | KARD | Kardigan, Inc. | Meeker David P | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 | |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | F - Tax | $108.99 | -31.5K | 239.0K | -12% | -$3.44M |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | — | +68.7K | 270.5K | +34% | — |
| D | 2025-06-05 | 2025-06-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | $4.59 | +43.6K | 245.4K | +22% | +$200.2K |
| DM | 2025-06-05 | 2025-06-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $65.04 | -43.6K | 201.8K | -18% | -$2.84M |
| D | 2025-02-19 | 2025-02-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $57.22 | -9,896 | 201.3K | -5% | -$566.2K |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | — | +21.2K | 211.2K | +11% | — |
| D | 2025-02-04 | 2025-02-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $59.43 | -4,278 | 189.9K | -2% | -$254.2K |
| D | 2025-02-04 | 2025-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | — | +14.1K | 194.2K | +8% | — |
| D | 2024-08-29 | 2024-08-27 | TRVI | Trevi Therapeutics, Inc. | Meeker David P | Dir | M - OptEx | $1.43 | +4,555 | 357.0K | +1% | +$6,514 |
| D | 2024-08-29 | 2024-08-27 | TRVI | Trevi Therapeutics, Inc. | Meeker David P | Dir | S - Sale+OE | $2.93 | -4,555 | 352.5K | -1% | -$13.3K |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale | $39.22 | -45.5K | 174.6K | -21% | -$1.78M | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | A - Grant | $0.00 | +99.0K | 220.1K | +82% | $0 |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | M - OptEx | — | +14.1K | 125.5K | +13% | — |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $45.06 | -4,361 | 121.1K | -3% | -$196.5K |
Purchase Sale Sale after option exercise All abbreviations